LA
IDXX icon

Legacy Advisors’s Idexx Laboratories IDXX Stock Holding History

Legacy Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$829K Buy
1,975
+48
+2% +$20.8K 0.09% 189
2024
Q4 		$797K Buy
1,927
+10
+0.5% +$4.39K 0.08% 193
2024
Q3 		$969K Sell
1,917
-826
-30% -$401K 0.1% 148
2024
Q2 		$1.34M Buy
2,743
+46
+2% +$23.1K 0.16% 100
2024
Q1 		$1.46M Buy
2,697
+224
+9% +$122K 0.18% 100
2023
Q4 		$1.37M Sell
2,473
-97
-4% -$45.5K 0.18% 102
2023
Q3 		$1.12M Buy
2,570
+137
+6% +$68.3K 0.18% 107
2023
Q2 		$1.22M Buy
2,433
+103
+4% +$49.4K 0.18% 99
2023
Q1 		$1.17M Buy
2,330
+57
+3% +$27.3K 0.21% 85
2022
Q4 		$927K Buy
2,273
+707
+45% +$274K 0.17% 95
2022
Q3 		$510K Buy
1,566
+384
+32% +$141K 0.11% 121
2022
Q2 		$415K Buy
1,182
+476
+67% +$194K 0.09% 137
2022
Q1 		$386K Buy
+706
New +$371K 0.08% 142

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Legacy Advisors's IDXX Position: Q1 2025 in Review

Legacy Advisors increased its Idexx Laboratories (IDXX) stake by 2.5% in Q1 2025, buying an estimated $20.8K and bringing the position to 1,975 shares worth $829K. The position accounts for 0.09% of the portfolio, ranked #189.

Legacy Advisors first reported a position in IDXX in Q1 2022 and has held it in 13 quarters since. The position peaked at $1.46M in Q1 2024. 1,144 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

  • Legacy Advisors held 1,975 shares of Idexx Laboratories worth $829K as of Q1 2025.
  • Legacy Advisors bought 48 Idexx Laboratories shares in Q1 2025, an estimated $20.8K.
  • Idexx Laboratories made up 0.09% of Legacy Advisors's portfolio in Q1 2025, its #189 holding.
  • Legacy Advisors first reported a position in Idexx Laboratories in Q1 2022 and has held it in 13 quarters since.
  • Legacy Advisors's Idexx Laboratories position peaked at $1.46M in Q1 2024.
  • 1,144 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Legacy Advisors's 13F filing for Q1 2025, filed 23 Apr 2025.